Current position and future trends of therapy for Crohn’s disease
Requires Subscription PDF

Keywords

biologic therapy
Crohn’s disease
infliximab
biological therapy
colonoscopy
colorectal surgery
hemoroidy
klinické zkoušky jako téma
kombinovaná terapie
lidé
metronidazol
monoclonal antibodies
oportunní infekce
pancreatic neoplasms
placeba
rektální píštěl
rektum
střevní sliznice
endoskopický index CDEIS
profylaxe rekurence
slizniční restituce
studie ACCENT I
studie EXTEND
studie MUSIC
studie PREVENT

Abstract

Despite significant progress in the therapy of Crohn's disease, many problems and unsolved approaches still remain. In this reviewthe author identifies and discusses some of them. Major consideration is focused on therapy of perianal Crohn's disease, on combination therapy with immunomodulators, and biologic therapy including the advantages and limitations of each. Additionally, the approach to patients after surgery and the choice of prophylactic therapy is discussed. At the end of this paper the position of musosal healing in Crohn's disease patients is discussed. It is recognized that mucosal healing has great importance for patients' prognosis after therapy has started, but an endoscopic evaluation of mucosal healing in Crohn's disease partients is far more problematic in comparision to ulcerative colitis patients. This is one reason why monitoring of mucosal healing is not currently standard clinical practice.

Requires Subscription PDF